Consult your state pharmacy board in addition to this guide
Compounded medications are not approved or evaluated for safety, efficacy, or quality by the FDA
Vivia Biotech has developed a precision medicine (PM) ex vivo test with 92% patients predicted to be sensitive and 75% overall survival at 3 years with a backbone first line treatment in AML patients
It's helpful to see how it stacks up against other well-known compounds
Nakamura A, Nakashima M, Sugao T, Kanemoto H, Fukumura Y, Shiomi H
For a comprehensive understanding of safety considerations, our peptide safety and risks guide covers contraindications, interactions, and monitoring recommendations in detail